Study data were based on a relatively small number of cases; however, the two groups were homogeneous by tumor grade, the median tumor size, T stage, stage of the disease and received chemotherapy (Table I) and only patients with two common germline founder BRCA1 mutations (4153delA and 5382insC) were included in the study. Here, BRCA1 is linked to neoplasm.